These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25082360)

  • 1. Improved outcome of critically ill patients with hematological malignancies: what's next?
    Soubani AO; Decruyenaere J
    Intensive Care Med; 2014 Sep; 40(9):1377-80. PubMed ID: 25082360
    [No Abstract]   [Full Text] [Related]  

  • 2. Time to look beyond one-year mortality in critically ill hematological patients?
    Moors I; Benoit DD
    Crit Care; 2014 Feb; 18(1):107. PubMed ID: 24517551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive care therapy for patients with hematological diseases.
    Anger B; Schmeiser T; Sigel H; Heimpel H
    Haematol Blood Transfus; 1987; 30():519-23. PubMed ID: 3623244
    [No Abstract]   [Full Text] [Related]  

  • 4. Characteristics and outcomes of haematology patients admitted to the intensive care unit.
    McCaughey C; Blackwood B; Glackin M; Brady M; McMullin MF
    Nurs Crit Care; 2013 Jul; 18(4):193-9. PubMed ID: 23782113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of critical care reconfiguration and track-and-trigger outreach team intervention on outcomes of haematology patients requiring intensive care admission.
    Bokhari SW; Munir T; Memon S; Byrne JL; Russell NH; Beed M
    Ann Hematol; 2010 May; 89(5):505-12. PubMed ID: 19876629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Survival and analysis of prognostic indices in patients with hematologic diseases treated in an intensive care unit].
    Arranz Sáez R; López Messa JB; Sánchez García M; Alonso P; González Gómez N; Solano Vercet C; Montalvo Burbano M; Torres Moldenhauer T; Fernández-Rañada JM
    Med Clin (Barc); 1986 May; 86(17):709-11. PubMed ID: 3736160
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictors of short and long-term outcome in patients with hematological disorders admitted to the intensive care unit for a life-threatening complication.
    Cherif H; Martling CR; Hansen J; Kalin M; Björkholm M
    Support Care Cancer; 2007 Dec; 15(12):1393-8. PubMed ID: 17516092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic critically ill patients from the perspective of hematologists/oncologists].
    Staudinger T; Schellongowski P
    Med Klin Intensivmed Notfmed; 2013 May; 108(4):295-302. PubMed ID: 23443518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematological issues in critically ill patients with cancer.
    Carlson KS; DeSancho MT
    Crit Care Clin; 2010 Jan; 26(1):107-32. PubMed ID: 19944278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognosis of the hematologic patients admitted to an Intensive Care Unit].
    Ferrà C; Ribera JM
    Med Clin (Barc); 2012 Dec; 139(14):631-3. PubMed ID: 22944211
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intensive care management of hematological and oncological patients].
    von Bergwelt-Baildon M; Shimabukuro-Vornhagen A; Hallek M; Kochanek M
    Internist (Berl); 2013 Sep; 54(9):1080-6. PubMed ID: 23963277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in critically ill patients with hematologic malignancies admitted to the intensive care unit.
    Yeo CD; Kim JW; Kim SC; Kim YK; Kim KH; Kim HJ; Lee S; Rhee CK
    J Crit Care; 2012 Dec; 27(6):739.e1-6. PubMed ID: 23217573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematologic failure.
    Levi M; Schultz M
    Semin Respir Crit Care Med; 2011 Oct; 32(5):651-9. PubMed ID: 21989700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing use of intensive care for hematological patients: the example of multiple myeloma.
    Azoulay E; Recher C; Alberti C; Soufir L; Leleu G; Le Gall JR; Fermand JP; Schlemmer B
    Intensive Care Med; 1999 Dec; 25(12):1395-401. PubMed ID: 10660847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the outcomes of Dutch haematological patients receiving intensive care support.
    van Vliet M; van der Burgt MP; van der Velden WJ; van der Hoeven JG; de Haan AF; Donnelly JP; Pickkers P; Blijlevens NM
    Neth J Med; 2014 Feb; 72(2):107-12. PubMed ID: 24659598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Main characteristics observed in patients with hematologic diseases admitted to an intensive care unit of a Brazilian university hospital.
    Barreto LM; Torga JP; Coelho SV; Nobre V
    Rev Bras Ter Intensiva; 2015; 27(3):212-9. PubMed ID: 26331970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of hematological patients after discharge from the intensive care unit: a prospective observational study.
    Bernal T; Pardavila EV; Bonastre J; Jarque I; Borges M; Bargay J; Ayestarán JI; Insausti J; Marcos P; González-Sanz V; Martínez-Camblor P; Albaiceta GM
    Crit Care; 2013 Dec; 17(6):R302. PubMed ID: 24377481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What's new in ... hematology].
    Delarue R
    Rev Prat; 2015 Sep; 65(7):941-4. PubMed ID: 26619731
    [No Abstract]   [Full Text] [Related]  

  • 19. [Survival of haematologic patients admitted to an Intensive Care Unit. A 16 years study].
    Jannone Forés R; Botella de Maglia J; Bonastre Mora J
    Med Clin (Barc); 2012 Dec; 139(14):607-12. PubMed ID: 22995845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with hematological malignancies admitted to intensive care units: new challenges for the intensivist.
    Torres VB; Soares M
    Rev Bras Ter Intensiva; 2015; 27(3):193-5. PubMed ID: 26465241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.